B.P. Koirala Institute of Health Sciences, is a Nepalese autonomous health sciences university. It is located in the sub-metropolitan city of Dharan in Sunsari District. The Institute is a Nepal-India cooperation.

During the past decade, B.P. Koirala Institute of Health Sciences conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 1 clinical trials were completed, i.e. on average, 4.5% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 1 clinical trials were completed. i.e. 9.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "B.P. Koirala Institute of Health Sciences" #1 sponsor was "B.P. Koirala Institute of Health Sciences" with 15 trials, followed by "International Vaccine Institute" with 2 trials sponsored, "Dr. Pradip Gyanwali,MD" with 1 trials sponsored, "London School of Hygiene and Tropical Medicine" with 1 trials sponsored and "Nepal Health Research Council" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "B.P. Koirala Institute of Health Sciences" #1 collaborator was "B.P. Koirala Institute of Health Sciences" with 3 trials as a collaborator, "Institute of Tropical Medicine, Belgium" with 2 trials as a collaborator, "EuBiologics Co.,Ltd" with 1 trials as a collaborator, "Gadjah Mada University" with 1 trials as a collaborator and "Institut de Recherche en Santé Publique, France" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "B.P. Koirala Institute of Health Sciences" are "Pain, Postoperative" (4 trials), "Acute Respiratory Illnesses" (1 trials), "Aeromonas Spp. Infections" (1 trials), "Amoebiasis" (1 trials) and "Anxiety" (1 trials). Many other conditions were trialed in "B.P. Koirala Institute of Health Sciences" in a lesser frequency.

Most popular intervention types in "B.P. Koirala Institute of Health Sciences" are "Drug" (14 trials), "Biological" (3 trials), "Device" (3 trials), "Other" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Lidocaine" (2 trials), "Normal saline" (2 trials), "(alprax) alprazolam" (1 trials) and "Amino acid solution" (1 trials). Other intervention names were less common.

The vast majority of trials in "B.P. Koirala Institute of Health Sciences" are 18 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "B.P. Koirala Institute of Health Sciences". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in B.P. Koirala Institute of Health Sciences, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in B.P. Koirala Institute of Health Sciences, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 7 trials that are defined as “Not Applicable".